Serum interleukin-6 and survivin levels predict clinical response to etanercept treatment in patients with established rheumatoid arthritis

Objectives: To investigate the correlation of nine potential biomarkers with clinical response to etanercept (ETN) therapy in establish rheumatoid arthritis (RA) patients. Methods: Seventy-three patients with established RA were enrolled in the prospective cohort study. Sixty-nine of 73 cases were i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Modern rheumatology 2018-01, Vol.28 (1), p.126-132
Hauptverfasser:	Shi, Rui, Chen, Muzhi, Litifu, Bahaerguli
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - blood Arthritis, Rheumatoid - drug therapy Biomarkers - blood Etanercept Etanercept - therapeutic use Female Humans Inhibitor of Apoptosis Proteins - blood Interleukin-1beta - blood interleukin-6 Interleukin-6 - blood Male Middle Aged predict Prospective Studies response survivin Treatment Outcome Tumor Necrosis Factor-alpha - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!